TipRanks
Reviva Pharmaceuticals Holdings (RVPH)
OTHER OTC:RVPH
US Market
RVPH
Reviva Pharmaceuticals Holdings
RESEARCH TOOLSreports
Want to see RVPH full AI Analyst Report?

Reviva Pharmaceuticals Holdings (RVPH) Ratios

1,277 Followers

Reviva Pharmaceuticals Holdings Ratios

RVPH's free cash flow for Q2 2026 was $0.00. For the 2026 fiscal year, RVPH's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Mar 25Mar 24Dec 22
Liquidity Ratios
Current Ratio
 3.56 2.08 1.01 1.38 1.90
Quick Ratio
 3.56 2.08 1.01 1.38 1.90
Cash Ratio
 3.35 1.98 0.92 1.36 1.86
Solvency Ratio
 -0.41 -2.73 0.06 0.01 -2.29
Operating Cash Flow Ratio
 -1.00 -3.38 -2.30 -1.65 -1.90
Short-Term Operating Cash Flow Coverage
 -41.06 -60.45 -73.22 0.00 0.00
Net Current Asset Value
$ 15.21T$ 7.83M$ -7.15K$ 5.72M$ 8.39M
Leverage Ratios
Debt-to-Assets Ratio
 <0.01 0.03 0.03 0.00 0.00
Debt-to-Equity Ratio
 <0.01 0.05 0.56 0.00 0.00
Debt-to-Capital Ratio
 <0.01 0.04 0.36 0.00 0.00
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.39 1.84 19.08 4.14 2.25
Debt Service Coverage Ratio
 -18.56 -47.23 -62.73 -1.16K -132.02
Interest Coverage Ratio
 891.84 -1.51K -1.67K -1.17K -132.97
Debt to Market Cap
 23.43K 0.02 <0.01 0.00 0.00
Interest Debt Per Share
 10.69K 0.12 0.29 <0.01 <0.01
Net Debt to EBITDA
 7.54 0.71 0.44 0.60 0.77
Profitability Margins
Gross Profit Margin
0.00%0.00%0.00%0.00%0.00%
EBIT Margin
0.00%0.00%0.00%0.00%0.00%
EBITDA Margin
0.00%0.00%0.00%0.00%0.00%
Operating Profit Margin
0.00%0.00%0.00%0.00%0.00%
Pretax Profit Margin
0.00%0.00%0.00%0.00%0.00%
Net Profit Margin
0.00%0.00%0.00%0.00%0.00%
Continuous Operations Profit Margin
0.00%0.00%0.00%0.00%0.00%
Net Income Per EBT
100.11%100.10%100.07%100.04%100.09%
EBT Per EBIT
93.42%98.25%97.08%99.34%100.05%
Return on Assets (ROA)
-11.58%-124.75%-192.99%-165.65%-128.62%
Return on Equity (ROE)
-64.39%-229.71%-3681.99%-686.53%-289.95%
Return on Capital Employed (ROCE)
-17.21%-233.59%-3416.09%-605.39%-271.23%
Return on Invested Capital (ROIC)
-17.05%-223.09%-2265.06%-605.39%-5.89%
Return on Tangible Assets
-11.58%-124.75%-192.99%-165.65%-128.62%
Earnings Yield
-38607539.91%-98.13%-49.87%-32.03%-29.34%
Efficiency Ratios
Receivables Turnover
 0.00 0.00 0.00 0.00 0.00
Payables Turnover
 0.00 0.00 0.00 0.00 0.00
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 0.00 0.00 0.00 0.00 0.00
Asset Turnover
 0.00 0.00 0.00 0.00 0.00
Working Capital Turnover Ratio
 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle
 0.00 0.00 0.00 0.00 0.00
Days of Sales Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 0.00 0.00 0.00 0.00 0.00
Operating Cycle
 0.00 0.00 0.00 0.00 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
 -447.93K -6.78 -20.24 -1.19 -0.97
Free Cash Flow Per Share
 -447.93K -6.78 -20.24 -1.19 -0.97
CapEx Per Share
 0.00 0.00 <0.01 <0.01 0.00
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
 0.00 0.00 -8.39M -9.44M 0.00
Capital Expenditure Coverage Ratio
 0.00 0.00 -8.39M -9.44M 0.00
Operating Cash Flow Coverage Ratio
 -41.06 -60.45 -73.22 0.00 0.00
Operating Cash Flow to Sales Ratio
 0.00 0.00 0.00 0.00 0.00
Free Cash Flow Yield
-96222599.94%-121.49%-55.91%-23.11%-22.86%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -0.07 -1.02 -2.01 -3.12 -3.41
Price-to-Sales (P/S) Ratio
 0.00 0.00 0.00 0.00 0.00
Price-to-Book (P/B) Ratio
 <0.01 2.34 73.84 21.43 9.88
Price-to-Free Cash Flow (P/FCF) Ratio
 >-0.01 -0.82 -1.79 -4.33 -4.37
Price-to-Operating Cash Flow Ratio
 >-0.01 -0.82 -1.79 -4.33 -4.37
Price-to-Earnings Growth (PEG) Ratio
 >-0.01 0.01 0.04 -0.23 -0.02
Price-to-Fair Value
 <0.01 2.34 73.84 21.43 9.88
Enterprise Value Multiple
 7.54 -0.31 -1.57 -2.53 -2.67
Enterprise Value
 -19.75T 6.21M 46.98M 99.19M 64.43M
EV to EBITDA
 7.54 -0.31 -1.57 -2.53 -2.67
EV to Sales
 0.00 0.00 0.00 0.00 0.00
EV to Free Cash Flow
 3.34 -0.25 -1.40 -3.50 -3.40
EV to Operating Cash Flow
 3.34 -0.25 -1.40 -3.50 -3.40
Tangible Book Value Per Share
 1.15M 2.38 0.49 0.24 0.43
Shareholders’ Equity Per Share
 1.15M 2.38 0.49 0.24 0.43
Tax and Other Ratios
Effective Tax Rate
 >-0.01 >-0.01 >-0.01 >-0.01 >-0.01
Revenue Per Share
 0.00 0.00 0.00 0.00 0.00
Net Income Per Share
 -185.32K -5.48 -18.05 -1.65 -1.25
Tax Burden
 1.00 1.00 1.00 1.00 1.00
Interest Burden
 231.37K 1.00 1.00 1.00 1.00
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 1.05 1.24 1.12 0.72 0.78
Currency in USD